搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
药品
/
akba
/
财务摘要
Akebia Therapeutics Inc
AKBA
添加自选
0.963
USD
+0.011
+1.16%
收盘 09-14 16:00(美东)
261.69M
总市值
亏损
市盈率 TTM
Akebia Therapeutics Inc
0.963
+0.011
+1.16%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
AKBA 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Akebia Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
261.69M
股息TTM
0.00
市盈率 TTM
-11.94
每股收益TTM
-0.08
营业收入
236.20M
净利润
-69.41M
净资产收益率
-78.96%
总资产收益率
-6.10%
Akebia Therapeutics Inc 财报日历
最新发布
8月 5, 2026
每股收益 / 预测值
-0.03
/-0.04
营业收入 / 预测值
49.13M
/48.86M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-3614.89%
-0.03
-230.64%
-0.03
55.76%
-0.05
102.14%
0.00
102.30%
0.00
129.57%
0.03
-3327.24%
-0.10
-23.82%
-0.10
31.57%
-0.04
39.67%
-0.09
106.45%
0.00
--
-0.08
--
-0.06
--
-0.15
--
-0.05
--
-0.48
--
--
--
--
--
--
--
--
营业收入
-21.36%
49.13M
-6.61%
53.54M
23.93%
57.62M
57.01%
58.77M
43.13%
62.47M
75.84%
57.34M
-17.26%
46.50M
-10.98%
37.43M
-22.58%
43.65M
-18.49%
32.61M
2.06%
56.20M
-13.69%
42.05M
-55.39%
56.38M
-35.16%
40.01M
-4.53%
55.06M
-0.09%
48.71M
138.82%
126.36M
17.96%
61.70M
2.93%
57.68M
-18.72%
48.76M
净利润
-3706.48%
-8.91M
-248.13%
-9.05M
46.31%
-12.24M
102.69%
540.00K
102.88%
247.00K
133.98%
6.11M
-3814.01%
-22.80M
-38.30%
-20.04M
23.18%
-8.58M
33.08%
-17.98M
106.66%
614.00K
73.22%
-14.49M
-137.94%
-11.17M
56.94%
-26.88M
86.81%
-9.22M
9.15%
-54.10M
135.46%
29.45M
10.29%
-62.42M
20.96%
-69.86M
0.69%
-59.54M
利润率
-4686.03%
-18.13%
-258.63%
-16.91%
56.67%
-21.25%
101.72%
0.92%
102.01%
0.40%
119.33%
10.66%
-4588.74%
-49.04%
-55.37%
-53.54%
0.78%
-19.66%
17.90%
-55.16%
106.53%
1.09%
--
-34.46%
--
-19.82%
--
-67.18%
--
-16.74%
--
-37.24%
--
--
--
--
--
--
--
--
毛利率
-2.46%
80.50%
-18.73%
69.75%
41.56%
82.06%
28.43%
81.66%
36.76%
82.53%
33.96%
85.83%
-11.90%
57.97%
11.99%
63.58%
-11.51%
60.34%
31.12%
64.07%
-58.23%
65.80%
--
56.78%
--
68.19%
--
48.86%
--
157.52%
--
61.42%
--
--
--
--
--
--
--
--
资产负债率
1.41%
55.01%
256.88%
53.51%
193.16%
51.40%
184.64%
52.71%
214.04%
54.24%
12.16%
14.99%
22.20%
17.53%
2.11%
18.52%
3.14%
17.27%
-26.41%
13.37%
-22.68%
14.35%
--
18.13%
--
16.75%
--
18.17%
--
18.56%
--
30.50%
--
--
--
--
--
--
--
--
利润表
营业收入
-21.36%
49.13M
-6.61%
53.54M
23.93%
57.62M
57.01%
58.77M
43.13%
62.47M
75.84%
57.34M
-17.26%
46.50M
-10.98%
37.43M
-22.58%
43.65M
-18.49%
32.61M
2.06%
56.20M
-13.69%
42.05M
-55.39%
56.38M
-35.16%
40.01M
-4.53%
55.06M
-0.09%
48.71M
138.82%
126.36M
17.96%
61.70M
2.93%
57.68M
-18.72%
48.76M
营业利润
-119.17%
-2.68M
-157.58%
-7.90M
56.40%
-5.45M
135.24%
3.95M
270.08%
13.99M
196.05%
13.71M
-847.13%
-12.51M
7.91%
-11.21M
6.43%
-8.22M
43.32%
-14.28M
-92.85%
1.67M
75.78%
-12.17M
-118.08%
-8.79M
56.93%
-25.19M
135.83%
23.41M
8.49%
-50.23M
161.26%
48.61M
9.92%
-58.49M
2.90%
-65.34M
5.52%
-54.89M
净利润
-3706.48%
-8.91M
-248.13%
-9.05M
46.31%
-12.24M
102.69%
540.00K
102.88%
247.00K
133.98%
6.11M
-3814.01%
-22.80M
-38.30%
-20.04M
23.18%
-8.58M
33.08%
-17.98M
106.66%
614.00K
73.22%
-14.49M
-137.94%
-11.17M
56.94%
-26.88M
86.81%
-9.22M
9.15%
-54.10M
135.46%
29.45M
10.29%
-62.42M
20.96%
-69.86M
0.69%
-59.54M
资产负债表
流动资产
-2.18%
229.55M
19.48%
243.48M
122.22%
252.96M
158.03%
258.34M
109.33%
234.66M
80.43%
203.78M
-3.65%
113.83M
-8.65%
100.12M
-5.36%
112.10M
-6.44%
112.94M
-36.20%
118.15M
-53.85%
109.60M
-61.06%
118.45M
-60.12%
120.72M
-31.70%
185.18M
-28.04%
237.51M
-8.13%
304.16M
-17.08%
302.69M
-27.00%
271.15M
-15.58%
330.08M
流动负债总额
35.50%
160.87M
90.61%
173.88M
101.37%
162.94M
102.98%
133.38M
10.64%
118.72M
37.21%
91.23M
-18.98%
80.91M
-17.56%
65.71M
16.40%
107.30M
-19.84%
66.49M
-22.90%
99.87M
-57.60%
79.70M
-60.55%
92.18M
-67.33%
82.94M
-50.38%
129.54M
-0.66%
187.97M
41.12%
233.68M
47.04%
253.91M
39.49%
261.05M
4.27%
189.21M
总资产
1.18%
349.66M
16.87%
362.52M
70.65%
376.56M
75.80%
364.15M
56.95%
345.60M
37.57%
310.19M
-8.70%
220.67M
-11.85%
207.14M
-13.21%
220.20M
-18.56%
225.48M
-32.12%
241.70M
-46.09%
235.00M
-51.38%
253.71M
-48.29%
276.86M
-32.74%
356.05M
-27.62%
435.89M
-14.72%
521.80M
-14.85%
535.36M
-17.82%
529.35M
-10.93%
602.27M
总负债
2.61%
324.64M
17.35%
335.14M
27.46%
343.95M
25.24%
322.56M
24.58%
316.37M
13.01%
285.60M
-0.89%
269.86M
-6.15%
257.54M
-9.47%
253.95M
-13.21%
252.74M
-22.39%
272.29M
-34.98%
274.42M
-38.95%
280.52M
-42.81%
291.21M
-22.95%
350.82M
-9.26%
422.04M
5.09%
459.50M
22.76%
509.24M
14.83%
455.34M
29.86%
465.12M
总权益
-14.39%
25.02M
11.37%
27.38M
166.30%
32.61M
182.52%
41.59M
186.58%
29.22M
190.18%
24.58M
-60.82%
-49.19M
-27.85%
-50.40M
-25.91%
-33.75M
-89.92%
-27.26M
-684.78%
-30.58M
-384.57%
-39.42M
-143.03%
-26.81M
-154.95%
-14.35M
-92.93%
5.23M
-89.90%
13.85M
-64.32%
62.30M
-87.79%
26.12M
-70.11%
74.01M
-56.87%
137.15M
现金流量表
经营净额
-84.22%
3.52M
-56.08%
-21.21M
797.02%
31.13M
519.79%
28.11M
321.98%
22.34M
30.08%
-13.59M
-93.50%
-4.47M
6.59%
-6.70M
-377.38%
-10.07M
-10.80%
-19.43M
95.78%
-2.31M
-121.20%
-7.17M
111.84%
3.63M
18.88%
-17.54M
12.94%
-54.68M
160.08%
33.80M
51.44%
-30.66M
69.44%
-21.62M
-104.04%
-62.81M
-106.59%
-56.27M
投资净额
-3137.30%
-4.08M
-140.26%
-62.00K
-393750.00%
-7.88M
-3750.00%
-77.00K
-334.48%
-126.00K
--
154.00K
--
-2.00K
--
-2.00K
--
-29.00K
--
--
--
0.00
--
0.00
--
0.00
100.00%
0.00
--
0.00
--
0.00
-100.00%
0.00
-100.57%
-114.00K
-100.00%
0.00
100.00%
0.00
融资净额
-480.12%
-6.54M
-101.24%
-926.00K
-121.72%
-4.85M
-8.99%
1.11M
-77.49%
1.72M
305.64%
74.94M
1830.62%
22.32M
2346.00%
1.22M
195.50%
7.64M
215.71%
18.48M
-128900.00%
-1.29M
100.15%
50.00K
-88788.89%
-8.00M
-133.58%
-15.97M
-100.02%
-1.00K
-299.84%
-32.94M
-100.02%
-9.00K
-36.16%
47.55M
-82.29%
5.40M
1463.76%
16.48M
常见问题
Akebia Therapeutics Inc的总收入是多少?
根据Akebia Therapeutics Inc的FY2025财报,总收入达到了236.20M(同比变化160.18M)。
Akebia Therapeutics Inc的流动资产是多少?
根据Akebia Therapeutics Inc的FY2025财报,流动资产为252.96M(同比变化122.22)。
Akebia Therapeutics Inc的总资产是多少?
根据Akebia Therapeutics Inc的FY2025财报,Akebia Therapeutics Inc的总资产为376.56M(同比变化70.65)。
Akebia Therapeutics Inc的总负债是多少?
根据Akebia Therapeutics Inc的FY2025财报,Akebia Therapeutics Inc的总负债为343.95M(同比变化27.46)。
Akebia Therapeutics Inc的总权益是多少?
根据Akebia Therapeutics Inc的FY2025财报,Akebia Therapeutics Inc的总权益为32.61M(同比变化166.30)。
Akebia Therapeutics Inc的净营业收入是多少?
根据Akebia Therapeutics Inc的FY2025财报,Akebia Therapeutics Inc的净营业收入为26.00M(同比变化156.26)。
Akebia Therapeutics Inc的净投资是多少?
根据Akebia Therapeutics Inc的FY2025财报,Akebia Therapeutics Inc的净投资为-7.93M(同比变化-23918.18)。
Akebia Therapeutics Inc的净融资是多少?
根据Akebia Therapeutics Inc的FY2025财报,Akebia Therapeutics Inc的净融资为72.93M(同比变化46.84)。
Akebia Therapeutics Inc的每股收益(EPS)是多少?
根据Akebia Therapeutics Inc的FY2025财报,每股收益(EPS)为-0.02(同比变化93.68)。
Akebia Therapeutics Inc的净利润是多少?
根据Akebia Therapeutics Inc的FY2025财报,净利润为-5.34M(同比变化92.30)。
Akebia Therapeutics Inc的净利润率是多少?
根据Akebia Therapeutics Inc的FY2025财报,净利润率为-2.26(同比变化94.78)。
Akebia Therapeutics Inc的毛利率是多少?
根据Akebia Therapeutics Inc的FY2025财报,毛利率为82.91(同比变化35.54)。
Akebia Therapeutics Inc的债务与资产比率是多少?
根据Akebia Therapeutics Inc的FY2025财报,债务与资产比率为51.40(同比变化-36.18)。
Akebia Therapeutics Inc的资产回报率(ROA)是多少?
根据Akebia Therapeutics Inc的FY2025财报,资产回报率(ROA)为-1.79(同比变化94.04)。
Akebia Therapeutics Inc的营业利润是多少?
根据Akebia Therapeutics Inc的FY2025财报,营业利润为26.00M(同比变化156.26)。